🧪EPA's New Chemical Regulation Findings
The Toxic Substances Control Act (TSCA) requires EPA to publish in the Federal Register a statement of its findings after its review of certain TSCA submissions when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to premanufacture notices (PMNs), microbial commercial activity notices (MCANs), and significant new use notices (SNUNs) submitted to EPA under TSCA. This document presents statements of findings made by EPA on such submissions during the period from June 1, 2025 to June 30, 2025.
Learn More🧪Proposed Tax Changes on Chloro-Isobutene-Isoprene Rubber
This notice of filing announces that a petition has been filed requesting that chloro-isobutene-isoprene rubber ((C<INF>4</INF>H<INF>8</INF>)<INF>n</INF>- (C<INF>5</INF>H<INF>7.31</INF>Cl<INF>0.69</INF>)<INF>m</INF>; n=97.75, m=2.25) be added to the list of taxable substances. This notice of filing also requests comments on the petition. This notice of filing is not a determination that the list of taxable substances is modified.
Learn More💊Chemtos LLC's Application for Bulk Manufacturing of Controlled Substances
Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊FDA Seeks Input on Onshoring Drug Manufacturing
The Food and Drug Administration (FDA, the Agency, or we) is announcing the establishment of a docket to solicit public comments on issues related to accelerating the establishment of new pharmaceutical manufacturing facilities in the United States. FDA is also announcing the following public meeting entitled "Onshoring Manufacturing of Drugs and Biological Products." At this meeting, FDA will present a draft framework that seeks to facilitate onshoring of pharmaceutical manufacturing. Participants will then engage in a guided discussion regarding the proposed framework, its strengths, weaknesses, and opportunities. The group will also discuss additional considerations that may help overcome current challenges faced by industry to onshoring the manufacturing of pharmaceuticals, including active pharmaceutical ingredients (APIs) and finished drug and biological products, and ideas and options within the bounds of FDA's statutory authority that could facilitate such onshoring of manufacturing.
Learn More🎨FDA Corrects Color Additive Listing for Gardenia Blue
The Food and Drug Administration (FDA or we) is correcting the order entitled "Listing of Color Additives Exempt from Certification; Gardenia (Genipin) Blue". In the order, FDA amended the color additive regulations to provide for the safe use of gardenia (genipin) blue in various foods, at levels consistent with good manufacturing practice (GMP). The order inadvertently misstated the methanol specification. This document corrects that error.
Learn More🍊Proposed Rule to Lower Brix Level for Pasteurized Orange Juice
The Food and Drug Administration (FDA or we) is proposing to amend the standard of identity for pasteurized orange juice (POJ) by lowering the minimum orange juice soluble solids content from 10.5[deg] to 10[deg] Brix. We tentatively conclude that this proposed amendment will promote honesty and fair dealing in the interest of consumers and provide industry greater flexibility in the manufacture of pasteurized orange juice. This action, if finalized, will respond to a citizen petition submitted by the Florida Citrus Processors Association Inc. and Florida Citrus Mutual Inc.
Learn More🚛Preliminary Countervailing Duty Determination on Thai Chassis
The U.S. Department of Commerce (Commerce) preliminarily determines that countervailable subsidies are being provided to producers and exporters of certain chassis and subassemblies thereof (chassis) from the Kingdom of Thailand (Thailand). The period of investigation is January 1, 2024, through December 31, 2024. Interested parties are invited to comment on this preliminary determination.
Learn More🇺🇸Proclamation on Made in America Week
The proclamation underscores a commitment to American manufacturing, urging support for domestic industries and innovation. It highlights initiatives that encourage investment and production on U.S. soil, aiming to revive a culture of craftsmanship while protecting consumers from misleading advertising on American-made claims.
Learn More🏭Regulatory Relief for Taconite Iron Ore Processing Proclamation
The proclamation addresses regulatory relief for taconite iron ore processing facilities by exempting them from new emissions standards for two years. This aims to preserve domestic production capabilities vital for national defense and industrial supply chains, acknowledging the need for viable emissions control technology before compliance.
Learn More🛠️Antidumping Duty Order on Steel Threaded Rod from China Continued
As a result of the determinations by the U.S. Department of Commerce (Commerce) and the U.S. International Trade Commission (ITC) that revocation of the antidumping duty (AD) order on certain steel threaded rod from the People's Republic of China (China) would likely lead to the continuation or recurrence of dumping and material injury to an industry in the United States, Commerce is publishing a notice of continuation of this AD and order.
Learn More